Investor profile
Sofinnova Telethon SCA-RAIF
Sofinnova Partners SAS · Italy
Investment focus
Start with the fit.
Sofinnova Telethon SCA-RAIF is an Italy-focused life sciences fund managed by Sofinnova Partners SAS. Launched in 2018 with the Telethon Foundation and totalling about EUR 108M, it makes early-stage investments in Italian biotech companies developing treatments for rare and genetic diseases. Portfolio companies include AAVantgarde Bio, Genespire and Alia Therapeutics.
EUACC Intelligence
Free preview
EUACC Intelligence
Research Sofinnova Telethon SCA-RAIF
Explore the record and prepare questions for the fund.
Your side of the introduction
List your startup →